Guidance on evaluating AI for use in breast screening
Find out more about the new Lancet Digital Health article on the UK NSC approach to reviewing evidence on AI in breast screening.
Farah is a senior evidence manager in the UK NSC evidence team, managing evidence review projects that are used to inform UK NSC recommendations to ministers. She is currently managing workstreams on the use of artificial intelligence in screening, research in blood spot screening and improving the use of mathematical modelling in screening. Farah also works at the London School of Hygiene and Tropical Medicine as a research fellow in infectious disease epidemiology.
Find out more about the new Lancet Digital Health article on the UK NSC approach to reviewing evidence on AI in breast screening.
Find out more about Blood Spot Task Group (BSTG) and how it is helping inform UK National Screening Committee (UK NSC) evaluations into screening for rare diseases.
An updated definition of targeted screening will help clarify the remit of the expanded UK NSC.
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
screening programmes.